Iperten

Manidipine Dihydrochloride, the active ingredient in Iperten, is a calcium channel blocker presented as an oral tablet for oral use. It works by relaxing arterial smooth muscle, thereby lowering blood pressure in adults with primary hypertension.

GNH USA supplies Iperten as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and reliable global distribution.

Manidipine, a dihydropyridine calcium channel blocker, is used in the management of arterial hypertension.

Hypertension: reduces systolic and diastolic blood pressure in patients with essential hypertension.

Manidipine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of the ankles or lower legs. - Dizziness: sensation of light‑headedness, especially when standing. - Tachycardia: increased heart rate. - Nausea: mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Myocardial infarction: rare occurrence of heart attack. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reactions: rash, itching, or hives. - Angioedema: swelling of face, lips, or throat. - Cardiac arrhythmias: irregular heart rhythms.

Before initiating therapy with Manidipine, several safety considerations should be observed.

- Blood pressure monitoring: regularly assess to avoid excessive hypotension. - Hepatic impairment: use with caution; dose adjustment may be required. - Concomitant antihypertensives: evaluate risk of additive blood‑pressure lowering effects. - Renal function: assess in patients with renal disease. - Abrupt discontinuation: taper gradually to prevent rebound hypertension. - Store below 25°C: keep in the original pack, protect from moisture.

Manidipine can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase plasma levels. - Grapefruit juice: can elevate drug concentration. - Other potent vasodilators: risk of severe hypotension. - Non‑dihydropyridine calcium channel blockers: additive cardiac effects. - Alpha‑blockers: may cause excessive blood‑pressure drop.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce effectiveness. - Diuretics: monitor electrolytes and blood pressure. - Beta‑blockers: watch for bradycardia. - NSAIDs: may blunt antihypertensive response. - Antidiabetic agents: monitor glucose control.